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Abstract 
Context: Nowadays, experiencing occasional anxiety is a common part of each 
person’s life. The number of anxious people has increased in this modern life 
style. This study aimed to review some researches as to accelerate searching for 
new anxiolytic treatments. 
Evidence Acquisition: Related articles were extracted from databases 
including PubMed, Google Scholar, Springer, Science Direct and Wiley. Forty-
eight articles were chosen. The articles were carefully considered, and after 
extracting information, they were categorized and integrated in the appropriate 
sequences to meet the needs of this study. 
Results: This review mentions the important brain regions involved in anxiety; 
it then continues with encapsulating some of the neurotransmitters’ and 
neuropeptides’ functions that cope with anxiety-like behaviors. 
Conclusion: With regard to the results, it is suggested that anxiety can be 
caused by change in the brains’ neurotransmitters level but more studies are 
needed to identify its exact mechanism. 
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1. Context 
     Anxiety is an overreaction to a situation 
[1, 2]. According to National Institute of 
Mental Health’s report, approximately 18% 
of adults in the United States are suffering 
from anxiety [3]. Different factors 
associated with anxiety disorders such as 
alteration in releasing pattern of some 
neurotransmitters in the brain involves in 
anxiety-related behaviors [4]. 
In addition to neurotransmitter, reports 
demonstrate that some molecular 
mechanisms and organelles of the cells have 
important roles in anxiety-related disorders 
[4], for example Mitochondria as an energy 
center of cell and lysosome which is 
involved in disposal of wasted materials in 
the cells. Anxiety is a common phenomenon 
in some lysosomal storage diseases  [5]. 
Also an indirect relation of cell membrane 
to anxiety has been proposed before. 
Microtubules are a component of the 
cytoskeleton in the cytoplasm. Microtubules 
are important in cell migration, mitosis, 
development and gene regulations; 
additionally, in indirect ways they can 
participate in anxiety-related behaviors. 
Peroxisome are organelles participating in 
catabolism of very long chain fatty acids 
and reduction of reactive oxygen species 
(ROS). It has been suggested that the 
increase in ROS production induces 
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anxiety. Also Endoplasmic reticulum 
function is related to anxiety as inhibition of 
endoplasmic reticulum stress decreases 
anxiety-like behavior induced by restrainer 
[6]. 
 
2. Evidence Acquisition 
     Related articles were extracted from 
databases including PubMed, Google 
Scholar, Springer, Science Direct and 
Wiley, with the following keywords or a 
combination of them: Anxiety; 
Neurotransmitter; Organelle; Neurobiology; 
Neurocircuitry. After a comprehensive 
search that was done based on the 
keywords, 48 articles were chosen. The 
articles were carefully considered, and after 
extracting information, they were 
categorized and integrated in the 




      The present study is a review article that 
was conducted in 2019. About 48 papers 
proved to be appropriate and after 
extraction, categorization and integration 
were formulated in the form of proper 
sequence for the purpose of the present 
study. Various methods such as behavioral 
tests, lesions studies and neuroimaging 
investigations have indicated that different 
parts of brain are engaged in anxiety 
disorders and anxiety-like behaviors [4]. 
Regions are listed below:  
 
3.1 Amygdala 
     In the bottom segment of the temporal 
lobe, a complex of several nuclei comprise 
an almond-shaped structure called 
Amygdala [7, 8]. This includes excitatory 
projection to basal forebrain, hypothalamus 
and brainstem structures [9]. Amygdala 
deals with different behavioral processes 
including memory formation and decision-
making [7].  
 
3.2 Hippocampus 
     Hippocampus, a part of limbic system, 
has a key role in spatial navigation and 
consolidation of memory [10]. There is a 
direct correlation between hippocampal 
volume and anxiety symptoms in patients 
who suffer from depression, showing 
hippocampal contributions in anxiety 
behavior [7]. 
 
3.3 Frontal Cortex  
     Frontal Cortex in the mammalian brain is 
placed at the front of each cerebral 
hemisphere which has different functional 
divisions [11]. It comprises of the 
dorsolateral, ventromedial, and orbital 
sectors which, all together,  have an 
important role in mammalian behaviors 
[11]. Amygdala activation causes an 
activation of anxiety neurocircuitry and Pre-
Frontal Cortex (PFC) is responsible for 
regulating this activation [11]. Structural 
changes accrue from anxiety consequences 
in hippocampus and the PFC which could 
increase the next neuropsychiatric 
disturbances [11, 12]. Amygdala, 
hippocampus and PFC are correlated to 
Hypothalamic-Pituitary-Adrenal (HPA) axis 
in direct and indirect ways [13]. 
 
3.4 Ventral Tegmental Area (VTA) 
     Ventral tegmental area (VTA) is an 
accumulation of neurons adjacent to midline 
on the basis of midbrain [14]. VTA has 
significant role in anxiety behavior [14]. 
 
3.5 Nucleus Accumbens (NAc) 
     Nucleus Accumbens (Nac) is a mass of 
neurons, participating in cortico-basal 
ganglia-thalamic loop [15] Nac is the 
inferior part of the striatum and is 
predominantly linked to the limbic system 
[15].  Nac is one of the most crucial brain 
regions, involved in psychiatric disorders 
especially those related to anxiety and 
substance addiction such as Bipolar 
Disorder, Attention Deficit Hyperactivity 
Disorder (ADHD) and Post-Traumatic 
Stress Disorder (PTSD) [16, 17]. 
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3.6 Transmitters Involved in Anxiety 
Dopamine is one of the most important 
neurotransmitters vital in the variation of 
anxiety in different parts of the brain [18, 
19]. Anxiety-like behaviors induced by 
anxiogenic or anxiolytic drugs are adjusted 
by mesocortical and mesolimbic pathways 
of dopaminergic system [19]. Furthermore, 
according to various studies, a vast range of 
brain functions like learning, memory and 
fear are modulated by dopamine receptors 
[19].   
Histaminergic fibers rise from rat’s 
tuberomammillary nucleus (TMN) and its 
damage can induce anxiolytic-like effects 
but, anxiogenic-like responses were 
promoted by the injection of histamine into 
the dorsal and ventral hippocampus and also 
Amygdala in mice [20, 21]. Effect of 
histamine on anxiety and other emotional 
states could be mediated by its effect on 
other neurotransmitters. Some effective 
anxiolytic drugs like Buspirone and 
Diazepam could reduce the production level 
of histamine in the rats’ brain [21]. 
Histamine injection in different parts of the 
brain has different effects on anxiety related 
behavior. For example, its injection in the 
ventral hippocampus and CeA has 
anxiogenic-like effects while its injection in 
dorsal hippocampus results in anxiolytic-
like behaviors in the EPM test [22].  
Acetylcholine is a neurotransmitter with 
distinct effects including arousal, attention, 
memory and motivation [23]. Cholinergic 
innervation from the basal forebrain to the 
cerebral cortex and hippocampus are 
involved in cognition [23]. There are two 
main types of cholinergic receptors, namely 
nicotinic and muscarinic ones [24]. 
The possibility of anxiety could be 
amplified in smoking persons, according to 
clinical studies based on tobacco 
consumption [25]. Nicotine increases 
activity of some parts of the brain such as 
CeA and NAc and also the firing rate of 
VTA dopaminergic neurons [26]. Lots of 
neurotransmitters in the CNS for instance 
acetylcholine, noradrenaline, dopamine, 
GABA, serotonin, glutamate and 
neuropeptides are affected by nicotine 
administration [27].  
Serotonin or 5-hydroxytryptamine (5-HT) 
is a monoamine neurotransmitter [28]. First-
line pharmacological treatment for anxious 
people is selective serotonin re-uptake 
inhibitors (SSRIs), such as anxiolytic agents 
which reduce the activity of amygdala and 
may attenuate serotonin formation; and yet, 
it has been shown that chronic 
administration of SSRI decreases serotonin 
synthesis [29]. 
The derivative substance is from the bark of 
Yohimbe, an evergreen tree found in 
Central and Western Africa, known as  
Yohimbine with indole alkaloid structure 
[30]. In high concentrations it interacts with 
serotonin and dopamine receptors [31]. 
Researches demonstrated that anxiety could 
be increased by releasing of 5-HT from the 
dorsal raphe nucleus (5-HTDRN), in mice 
[32].  
Glutamate is one of the main excitatory 
neurotransmitters in the CNS is Glutamate 
[33]. Glutamate has different roles in 
cognitive and non-cognitive processes 
comprising neurodevelopment, learning and 
memory, pathogenesis of anxiety-related 
disorders, psychiatric conditions like 
schizophrenia and mood disorders [33]. 
Glutamate has different ionotropic and 
metabotropic receptors existing in high 
density in regions like the cortical and 
limbic [18]. The role of glutamate  N-
methyl-D-aspartate receptor NMDARs 
subtype in anxiety-like behavior is clearly 
recognized [34]. Studies have shown that in 
anxiety-like behaviors, the hippocampal 
glutamate N-methyl-D-aspartate receptor 
(NMDAR)s play important roles [35]. 
Adrenaline (epinephrine) or noradrenaline 
(norepinephrine) system has three types of 
receptors including α1, α2 or β-adrenergic 
receptors. α1-adrenergic receptors 
antagonists may be used in anxiety 
treatment [36]. IP injection of alpha-1 
adrenergic antagonist (Prazosin) has an 
anxiolytic effect among rats [37]. Likewise, 
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in other studies, the anxiogenic properties of 
α- and β-adrenergic neurotransmissions 
have been revealed [38]. Systemic blockade 
of α2-adrenoceptors (using Yohimbine) led 
to a decrease of fear [39]. Salbutamol, 
known as adrenergic β2 receptor agonists 
(the highest dose), decreased anxiety [39]. 
Anxiolytic response occurred by the 
cooperation of salbutamol and ineffective 
dose of morphine [39]. The basolateral 
amygdala complex (BLA) administration of 
beta-adrenergic antagonist propranolol 
(4µg/rat) decreased OAT% [39].  
Nitric Oxide (NO) system plays an 
underlying role in relaxation of blood 
vessels, and also regulates many biological 
processes in CNS including anxiety [40]. In 
stressful situations, synthesis of NO 
increases as a neuromodulator that can 
change other messengers’ activities [41]. 
 NO is synthesized by the function of a 
group of enzymes called Nitric Oxide 
synthase (NOS) which mediates the 
conversion of L-arginine to L-citrulline to 
produce NO as a byproduct [21].  Neuronal 
NOS usually exists in neuronal cell bodies, 
dendrites, and axons, mostly expressed in 
the CNS, containing the cerebral cortex, 
hippocampus, striatum, hypothalamic and 
amygdaloidal nuclei, and mesencephalon 
constructions that are suggested to 
dramatize the variation of anxiety-like 
conditions in the brain [21]. NO has a role 
in learning and memory processing by 
regulating long-term potentiation and long-
term depression, so it is involved in neural 
plasticity and mood related disturbances 
like anxiety [42]. To date, different/opposite 
effects of NO on anxiety have been 
reported, manifesting dose and time 
dependent effects of NO [42]. 
Gamma-Aminobutyric Acid (GABA) is 
an inhibitory neurotransmitter [43, 44]. The 
effect of GABA on anxiety depends on its 
combination with other neurotransmitters. 
GABA content within ventromedial 
prefrontal cortex (vmPFC) is important in 
the physiology of anxiety [45]. Glutamic 
acid decarboxylase 2 (Gad2) GAD2 is an 
enzyme catalyzing the decarboxylation of 
glutamate to GABA and CO2 [46]. Genetic 
studies both on animal and human 
investigations have revealed an important 
role of it in anxiety disorders [46]. 
Synthesis of Neurosteroids as allosteric 
modulators of the GABAA receptors  is 
regulated by stress and by anxiogenic 
stimuli [42]. The results of studies suggest 
that during early-life, anxiety- and 
depression-related behaviors can be 
influenced by GABA-A receptor, signaling 
in a time- and dose-dependent manner in 
later life [47]. Among different regions of 
the brain, the ventromedial prefrontal cortex 
(vmPFC) has a vital role in processing and 
regulation of emotion [47]. It is suggested 
that dysfunction of vmPFC can lead to 
disinhibition of amygdala, causing high 
anxiety levels [48]. The flow of information 
to amygdala is shaped by GABA inter-
neurons within vmPFC. Therefore, studies 
assume that GABA content within vmPFC 
can be associated with anxiety [48]. 
 
4. Conclusion 
     Fear is an emotional response in a 
normal range to threatening stimuli [49]. In 
anxiety disorders, the response is not 
normal and disturbs daily life [49]. Anxiety 
can be caused by aversive experiences, and 
also change in the brains’ neurotransmitters 
level [38]. Further studies are needed to 
identify promising treatments, using animal 
models based on neurobiology of this 
disorder, especially among women. Most of 
the experimental studies are in male, but it 
is widely accepted that the rate of anxiety in 
women is more than men [50].  
This review summarized some recent 
researches on mediators, moderators and 
associations between the different brain 
regions, transmitters, molecules and 
anxiety. As mentioned in the manuscript, 
the imbalance in the brain neurotransmitters 
can alter mood and behavior situations, 
leading to anxiety. Based on widespread 
studies, anxiety disorder is a result of both 
genetic and inappropriate environmental 
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factors.  Knowing the biochemistry related 
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